Semaglutide
Semaglutide is the active molecule behind Novo Nordisk’s three flagship products: Ozempic (T2D injection), Wegovy (weight loss injection + the new oral pill version), and Rybelsus (oral once-daily). Same molecule, different doses, different FDA-approved uses, very different prices. Our semaglutide coverage clarifies which formulation fits which patient, how compounded versions compare, and what the cardiovascular evidence shows.